Menu

Blog

Page 9151

Dec 8, 2017

Netflix’s Beautiful New Sci-Fi Series Will Make You Rethink Death

Posted by in categories: life extension, neuroscience

What is a body other than the vessel for your consciousness? Does the one you’re using right now really matter all that much? Why not, when your current body gets all old and run down, don’t you just get a new, young, beautiful, and healthy one? That’s the pitch in the first trailer for Netflix’s new dystopian sci-fi series Altered Carbon, which takes the form of an advertisement for Psychasec.

“Centuries ago, mankind discovered a way to transfer consciousness into a new body making death a mere inconvenience,” says the commercial. “Since then we’ve been providing an unparalleled pedigree of human sleeves to only the most discerning clientele. Psychasec: Live forever in the body you deserve.”

Continue reading “Netflix’s Beautiful New Sci-Fi Series Will Make You Rethink Death” »

Dec 7, 2017

Tesla just received its largest preorder of Semi trucks yet

Posted by in category: transportation

Anheuser-Busch says it reserved 40 electric big rigs.

Read more

Dec 7, 2017

DeepMind’s AI became a superhuman chess player in a few hours, just for fun

Posted by in category: robotics/AI

The descendant of DeepMind’s world champion Go program stretches its muscles in a new domain.

Read more

Dec 7, 2017

A Modified CRISPR Could Treat Common Diseases Without Editing DNA

Posted by in categories: bioengineering, biotech/medical, genetics

It worked. Working with mice, they were able to reverse the disease symptoms of kidney disease, type 1 diabetes, and a form of muscular dystrophy. In the mouse with kidney disease, for example, they turned on two genes associated with kidney function and saw the kidney function improved.


The unassumingly named CRISPR/Cas9 is a technology that stands to remake the world as we know it. By allowing scientists to more easily than ever cut and paste all those As, Cs, Ts, and Gs that encode all the world’s living things, for one thing, it could one day cure many devastating diseases.

All that power, though, comes with one pretty sizable caveat: Sometimes CRISPR doesn’t work quite like we expect it to. While the scientific establishment is still embroiled in a debate over just how serious the problem is, CRISPR sometimes causes off-target effects. And for scientists doing gene editing on human patients, those mutations could wind up inadvertently causing problems like tumors or genetic disease. Yikes.

Continue reading “A Modified CRISPR Could Treat Common Diseases Without Editing DNA” »

Dec 7, 2017

This is Aubrey — I’m starting the AMA now and I should be here for the next two hours. : Futurology

Posted by in category: biotech/medical

Read more

Dec 7, 2017

Google’s AI mastered chess in 4 hours

Posted by in categories: entertainment, robotics/AI

The robots are coming for your … chess game.

Google’s AI, AlphaZero, developed a “superhuman performance” in chess in just four hours.

Essentially, the AI absorbed humanity’s entire history of chess in one-sixth of a day — and then figured out how to beat anyone or anything.

Continue reading “Google’s AI mastered chess in 4 hours” »

Dec 7, 2017

Oldest Monster Black Hole Ever Found Is 800 Million Times More Massive Than the Sun

Posted by in category: cosmology

Scientists have found the oldest, farthest monster black hole yet, one that grew to gargantuan proportions just 690 billion years after the Big Bang.

Read more

Dec 7, 2017

AlphaZero Annihilates World’s Best Chess Bot After Just Four Hours of Practicing

Posted by in categories: entertainment, robotics/AI

Awesome!


A few months after demonstrating its dominance over the game of Go, DeepMind’s AlphaZero AI has trounced the world’s top-ranked chess engine—and it did so without any prior knowledge of the game and after just four hours of self-training.

AlphaZero is now the most dominant chess playing entity on the planet. In a one-on-one tournament against Stockfish 8, the reigning computer chess champion, the DeepMind-built system didn’t lose a single game, winning or drawing all of the 100 matches played.

Continue reading “AlphaZero Annihilates World’s Best Chess Bot After Just Four Hours of Practicing” »

Dec 7, 2017

Bitcoin: up 120% in less than 2 months

Posted by in categories: bitcoin, cryptocurrencies, economics

At the end of October, I delivered a keynote speech at the Cryptocurrency Expo in Dubai. That was just 5 weeks ago. When I left for the conference, Bitcoin was trading at $6,300/BTC. But in the next few weeks, it reached $10,000. Last week, I liquidated part of my investment at just under $13,000/BTC. Now, Bitcoin is about to cross $16,000. (I began writing this 10 minutes ago…but it has risen another $1600.00. Now, it is $17,000).

Dear Reader: I believe in Bitcoin. Yet, there is a “But” in the last paragraph below…

I believe in Bitcoin. Its rise is not fueled solely by investor hysteria. Rather, it is a product of delayed appreciation for a radical, transformative network technology.

Continue reading “Bitcoin: up 120% in less than 2 months” »

Dec 7, 2017

Siddhartha Mukherjee meets Henry Marsh: ‘When do you stop treating a patient? At 100?’

Posted by in categories: biotech/medical, genetics, neuroscience

Mukherjee is now 47 and lives in New York; Marsh, 67, lives in Oxford. To different extents both of these doctors still practise in their respective fields – Mukherjee at Columbia University’s cancer centre, Marsh as a visiting doctor at various hospitals around the world, including in Kathmandu in Nepal. Both men have continued to write: Marsh a second volume of autobiography, called Admissions, published this year, and Mukherjee a study of genetics called The Gene: An Intimate History, published last year. When they sat down to talk to each other over Skype one Saturday afternoon in November, they began with a subject on which their two lifelong disciplines overlap: the treatment of brain cancer.


The cancer specialist and the neurosurgeon talk about treating cancer, writing and facing death in their own families by .

Read more